MDPI and ACS Style
Ismail, T.; Alzneika, S.; Riguene, E.; Al-maraghi, S.; Alabdulrazzak, A.; Al-Khal, N.; Fetais, S.; Thanassoulas, A.; AlFarsi, H.; Nomikos, M.
BRCA1 and Its Vulnerable C-Terminal BRCT Domain: Structure, Function, Genetic Mutations and Links to Diagnosis and Treatment of Breast and Ovarian Cancer. Pharmaceuticals 2024, 17, 333.
https://doi.org/10.3390/ph17030333
AMA Style
Ismail T, Alzneika S, Riguene E, Al-maraghi S, Alabdulrazzak A, Al-Khal N, Fetais S, Thanassoulas A, AlFarsi H, Nomikos M.
BRCA1 and Its Vulnerable C-Terminal BRCT Domain: Structure, Function, Genetic Mutations and Links to Diagnosis and Treatment of Breast and Ovarian Cancer. Pharmaceuticals. 2024; 17(3):333.
https://doi.org/10.3390/ph17030333
Chicago/Turabian Style
Ismail, Tala, Safa Alzneika, Emna Riguene, Salwa Al-maraghi, Aya Alabdulrazzak, Noof Al-Khal, Sara Fetais, Angelos Thanassoulas, Halema AlFarsi, and Michail Nomikos.
2024. "BRCA1 and Its Vulnerable C-Terminal BRCT Domain: Structure, Function, Genetic Mutations and Links to Diagnosis and Treatment of Breast and Ovarian Cancer" Pharmaceuticals 17, no. 3: 333.
https://doi.org/10.3390/ph17030333